Hadean Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
SAGA Diagnosticssagadiagnostics.comin𝕏Jun 2021
SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Roopom Banerjee(Executive Chairman)in
Co-investorsFSGLU InnovationSciety
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.